Pfizer Stock Falls to 10-Year Low on Guidance Slash. Why Wall Street Is Disappointed.

Pfizer stock was trading at a 10-year low on Wednesday after the pharmaceutical company slashed its 2024 guidance. 

Continue reading this article with a Barron’s subscription.

View Options

Leave a Comment